Roll over image to zoom in
Hepcinat & Natdac (Sofosbuvir/ Daclatasvir) online
$269.00
Status: In stock
269.00 per 28 Tablets
Sofosbuvir and Daclatasvir are hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir, with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 infection. Limitations of Use: • Sustained virologic response (SVR12) rates are reduced in genotype 3 patients with cirrhosis receiving DAKLINZA in combination with sofosbuvir for 12 weeks.
Related products
Recently Viewed Products
